The expected $4.74 million in cash can support BioVie's needs, but the new shares give existing owners a smaller stake. The report names no use for the cash, so neither side clearly outweighs the other.
The cash gives BioVie more money for its needs, but the sale also gives existing owners a smaller share of the company. The report names no use for the cash, so neither side clearly outweighs the other.
Follow BioVie Inc. (BIVI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIVI